Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01792583 · ClinicalTrials.gov registry record
The Nuvigil and Provigil Pregnancy Registry
A clinical trial, sponsored by Cephalon.
- Terminated
- Registry status
- 191
- Enrollment target
NCT01792583 is a clinical trial that was terminated before completion, run by Cephalon. The registered enrollment target is 191 participants.
The verdict
NCT01792583 was terminated before completion, sponsored by Cephalon.
- TERMINATED
- Registry status
- 191 participants
- Enrollment target
Study Summary
The primary objective of the Nuvigil/Provigil Pregnancy Registry is to characterize the pregnancy and fetal outcomes associated with Nuvigil and Provigil exposure during pregnancy.
Interventions
- DRUG Modafinil/armodafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2009-06-30 |
| Est. Completion | 2023-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01792583
The ClinicalTrials.gov registry entry for NCT01792583 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 191 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cephalon, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Modafinil/armodafinil is the first listed.
NCT01792583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01792583 about?
NCT01792583 is a clinical study titled "The Nuvigil and Provigil Pregnancy Registry". The primary objective of the Nuvigil/Provigil Pregnancy Registry is to characterize the pregnancy and fetal outcomes associated with Nuvigil and Provigil exposure during pregnancy.
What is the current status of trial NCT01792583?
This trial is currently terminated. The enrollment target is 191 participants. The study started on 2009-06-30. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT01792583?
The interventions under investigation include: Modafinil/armodafinil (DRUG).
Who is sponsoring clinical trial NCT01792583?
This trial is sponsored by Cephalon, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.